Log in to save to my catalogue

Outcome in Multiple Myeloma Patients Eligible for Stem Cell Transplantation: A Single-Center Experie...

Outcome in Multiple Myeloma Patients Eligible for Stem Cell Transplantation: A Single-Center Experie...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_crossref_primary_10_1159_000437055

Outcome in Multiple Myeloma Patients Eligible for Stem Cell Transplantation: A Single-Center Experience

About this item

Full title

Outcome in Multiple Myeloma Patients Eligible for Stem Cell Transplantation: A Single-Center Experience

Publisher

Basel, Switzerland: S. Karger AG

Journal title

Oncology, 2015-09, Vol.89 (4), p.196-204

Language

English

Formats

Publication information

Publisher

Basel, Switzerland: S. Karger AG

More information

Scope and Contents

Contents

Autologous hematopoietic stem cell transplantation (ASCT) is the standard of care for selected patients with multiple myeloma (MM). Many data exist on ASCT in the era of novel agents. We retrospectively analyzed 189 patients (108 males and 81 females) with biopsy-proven MM, who had received ASCT after induction therapy with either conventional chem...

Alternative Titles

Full title

Outcome in Multiple Myeloma Patients Eligible for Stem Cell Transplantation: A Single-Center Experience

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_crossref_primary_10_1159_000437055

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_crossref_primary_10_1159_000437055

Other Identifiers

ISSN

0030-2414

E-ISSN

1423-0232

DOI

10.1159/000437055

How to access this item